Eli Lilly (NYSE: LLY)
Eli Lilly Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts
Consensus price targets set by experts who follow these businesses are way above their recent prices.
Where Will Eli Lilly Be in 3 Years?
The weight-loss drug opportunity could approach $100 billion by the end of the decade.
Top Commercial Real Estate Stocks
Commercial real estate stocks offer opportunities to get involved with some of the most interesting businesses in the world.
The Largest Companies by Market Cap in August 2025
Nvidia, Microsoft, and Apple are the biggest companies by market cap.
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
These two longtime market leaders should continue to perform well.
Stevens Capital Closes Out Position in Eli Lilly
Why Eli Lilly Stock Trounced the Market on Tuesday
The pharma giant advanced a medication that could be extremely competitive in a high-profile segment.
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
There are some reasons to be worried; there are also reasons to be optimistic.
Valuation
Podcast Episodes
The Problem With Weight Loss Stocks
There are new ways to tackle weight loss, but the stocks leading the way are lagging.
Is It Time to Buy Biotech Stocks?
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?
The State of Weight Loss Drugs
None
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues.
Earnings Transcripts
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2024.
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2024.
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2024.
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.